SONOMOTION COMPLETES ENROLLMENT IN PIVOTAL CLINICAL TRIAL FOR BREAK WAVE™ SYSTEM AND SECURES $2.2 MILLION NIH GRANT

SONOMOTION COMPLETES ENROLLMENT IN PIVOTAL CLINICAL TRIAL FOR BREAK WAVE™ SYSTEM AND SECURES $2.2 MILLION NIH GRANT

Clinical data to support FDA 510(k) submission for the noninvasive Break Wave systemProcedure is designed to fragment kidney stones using low pressure ultrasound waves in fully awake patients, without anesthesia, in the office or clinicCompany secures a $2.2M Fastrack NIH…

Pivotal trial of Break Wave System for stone disease reaches enrollment goal

Data from the SOUND trial are intended to support submission for FDA 510(k) clearance of the Break Wave device.